Home » Topics » Disease categories and therapies » Endocrine/metabolic

Endocrine/metabolic
RSS

Takeda researches follow-up compounds to leuprorelin

Jan. 31, 1997

No Comments

Mixed CCK-A agonist/CCK-B antagonist from Glaxo Wellcome

Jan. 30, 1997

No Comments

NutraGenics changes name, receives patent coverage for proprietary technology

Jan. 30, 1997

No Comments

Pfizer reveals agents for hypercholesterolemia, atherosclerosis

Jan. 30, 1997

No Comments

Antisense compound targeting cholesterol reported

Jan. 29, 1997

No Comments

MK-677 enhances GH activity in the elderly

Jan. 29, 1997

No Comments

TKT product advances toward the clinic

Jan. 29, 1997

No Comments

Japanese researchers isolate novel ACAT inhibitor

Jan. 29, 1997

No Comments

GHRP mimetics reported by Pfizer for treatment of osteoporosis

Jan. 29, 1997

No Comments

Hypocholesterolemic activity of raloxifene established in rats

Jan. 28, 1997

No Comments

BioWorld Premium

Enjoy extended coverage for the most complete market view with BioWorld, BioWorld MedTech, and BioWorld Asia in a single, easy to access subscription.

Endocrine/metabolic
RSS

Takeda researches follow-up compounds to leuprorelin

Mixed CCK-A agonist/CCK-B antagonist from Glaxo Wellcome

NutraGenics changes name, receives patent coverage for proprietary technology

Pfizer reveals agents for hypercholesterolemia, atherosclerosis

Antisense compound targeting cholesterol reported

MK-677 enhances GH activity in the elderly

TKT product advances toward the clinic

Japanese researchers isolate novel ACAT inhibitor

GHRP mimetics reported by Pfizer for treatment of osteoporosis

Hypocholesterolemic activity of raloxifene established in rats

Today's news in brief

Today's news in brief

Enhanced Cognition: Lewy body dementia phase II pumps stock

Second insulin receptor offers new therapeutic avenues

Experimental mRNA gene therapy suppresses preeclampsia in mice

Endocrine/metabolic RSS

Endocrine/metabolic
RSS